Re-participation In Screening For Colorectal Cancer: Behavioural Outcomes And Predictors.
Funder
National Health and Medical Research Council
Funding Amount
$687,438.00
Summary
Screening for bowel cancer (CRC) is an important public health initiative. It is most effective when undertaken regularly but there is little research on what personal factors relate to ongoing participation in a screening program. This study will determine the factors associated with ongoing participation in CRC screening and will lead to better screening programs and improved health benefits. This study directly addresses the Cancer Australia priority area re improving screening programs.
Centre For Research Excellence In Cervical Cancer Control (C4)
Funder
National Health and Medical Research Council
Funding Amount
$2,486,383.00
Summary
Cervical cancer remains common globally despite over 50 years of Pap testing. Australia led the world in HPV vaccination and in 2017 will be the first to deliver a national screening program based on HPV testing. Our CRE, led by cervical cancer prevention experts at CCNSW,VCS, and Kirby, will marry cross-disciplinary research and evaluation of HPV vaccination and screening to provide solid evidence about these new approaches with a view to ultimately reducing the global burden of this cancer.
Screening For Colorectal Cancer: Attitudes Affecting Participation And Implementation Of Strategies For Improvement.
Funder
National Health and Medical Research Council
Funding Amount
$468,760.00
Summary
There is good evidence that population screening for bowel cancer (CRC), based on the detection of blood in stools, is effective in reducing deaths from bowel cancer by around 30-40%. Screening depends on the use of a simple test to identify those who most need the complex and costly test which is capable of accurately detecting curable cancers and precancer lesions. This can be achieved with moderate effectiveness using simple tests (FOBTs) which detect microscopic amounts of blood in the faece ....There is good evidence that population screening for bowel cancer (CRC), based on the detection of blood in stools, is effective in reducing deaths from bowel cancer by around 30-40%. Screening depends on the use of a simple test to identify those who most need the complex and costly test which is capable of accurately detecting curable cancers and precancer lesions. This can be achieved with moderate effectiveness using simple tests (FOBTs) which detect microscopic amounts of blood in the faeces. If we are to reduce the rate of death from CRC, we must have an effective way of encouraging people to do these tests. While much has been learnt from experience with screening for breast and cervical cancer, CRC presents a series of quite different issues that have never been comprehensively studied. These are: (1) men and women need to be screened. (2) symptoms due to CRC are more complex , (3) the high-risk settings for CRC are much more complex), (4) the community is not as aware of the benefit of screening, (5) the initial test can be performed at personal convenience in one's home, (6) participants must handle bodily excretions, and (7) inconvenience of attending a central facility is avoided. We will survey participants and non-participants to more accurately identify the barriers to screening, and the proportion who have not participated for informed reasons. To test the real value of attempts to overcome these, we will then offer screening by various approaches designed to overcome these. We are in a unique position to do this as we have well-identified populations who have been offered faecal occult blood test (FOBT)-based screening These studies will assist in the design and implementation of effective screening programs for the early detection of CRC in Australia, which in the long term will significantly reduce deaths from this disease.Read moreRead less
Population Testing Of An Internet-based Personalised Decision Support System For Colorectal Cancer Screening
Funder
National Health and Medical Research Council
Funding Amount
$480,230.00
Summary
This study will determine the impact of a fully developed computerised Personalised Decision Support (PDS) package on colorectal cancer screening participation. The PDS tool is designed to guide people through the decision processes relevant to deciding whether to undertake screening. The PDS presents personally tailored messages aimed at progressing individuals towards screening test use and has the potential to supplement traditional paper methods of increasing screening participation.
A Population Based Communication Strategy To Optimise Colorectal Cancer Screening Behaviour In Australia.
Funder
National Health and Medical Research Council
Funding Amount
$532,425.00
Summary
There is good evidence that population screening, based on the detection of blood in faeces, is effective in reducing deaths from bowel cancer (CRC) by around 30-40%. The process depends on the use of a simple faecal occult blood test (FOBT) to identify those who need a more complex and costly test (colonoscopy), which is capable of accurately detecting curable cancers and precancers so that they can be removed. If we are to reduce deaths from CRC at the population level, we must have an effecti ....There is good evidence that population screening, based on the detection of blood in faeces, is effective in reducing deaths from bowel cancer (CRC) by around 30-40%. The process depends on the use of a simple faecal occult blood test (FOBT) to identify those who need a more complex and costly test (colonoscopy), which is capable of accurately detecting curable cancers and precancers so that they can be removed. If we are to reduce deaths from CRC at the population level, we must have an effective way of encouraging as many people as possible to do FOBT tests. While much has been learnt about how to offer screening from experience with programs for breast and cervical cancer, CRC screening involves different behavioural, psychological and social issues. We need to better understand how these factors influence participation in CRC screening. We plan a series of studies that will lead to improvements in participation in CRC screening programs: a) a survey of a randomly selected group of the general population to measure a range of behavioural features that are of importance to CRC screening, especially as they relate to participation. b) an offer of FOBTscreening to those invited to complete the survey, to match population characteristics with intentions and actual participation, c) on the basis of these studies, to design new screening program strategies, especially in relation to the communication of messages to encourage community participation, d) to test the effectiveness of the new communication strategies by offering FOBT screening to another randomly selected group from the general population. This will allow us to optimise the delivery of messages that encourage participation. If we can design a better communication strategy that achieves an increase in screening participation and has minimum cost implications, we will substantially reduce the number of deaths from CRC in Australia.Read moreRead less
Reducing The Burden Of Cancer In Chronic Kidney Disease
Funder
National Health and Medical Research Council
Funding Amount
$257,561.00
Summary
Chronic kidney disease (CKD) is an important public health problem in Australia and worldwide. Not only does CKD predisposes to end-stage kidney disease, but more importantly, increases the risk of co-morbidities such as cancer and cardiovascular disease, leading to premature death. As an academic nephrologist with interests in clinical epidemiology, health economics and translation research, this proposed program of work will focus on assessing the critical areas in improving the cancer outcome ....Chronic kidney disease (CKD) is an important public health problem in Australia and worldwide. Not only does CKD predisposes to end-stage kidney disease, but more importantly, increases the risk of co-morbidities such as cancer and cardiovascular disease, leading to premature death. As an academic nephrologist with interests in clinical epidemiology, health economics and translation research, this proposed program of work will focus on assessing the critical areas in improving the cancer outcomes in patients with CKD.Read moreRead less
Assessment Of The Effects Of Pathogenic Germline TP53 Mutations; International Sarcoma Kindred Study Participants’ Views Of Feedback Of Genetic Research Results And The Acceptability Of Taking Part In A Pilot Screening Programme
Funder
National Health and Medical Research Council
Funding Amount
$55,242.00
Summary
The International Sarcoma Kindred Study (ISKS) aims to identify individuals who harbour germline TP53 mutations. TP53 mutations are characterised by the development of multiple cancers including sarcoma. This project will assess ISKS participants’ views of the feedback of genetic research information and will develop sensitive feedback practices. The acceptability and psychological impact of taking part in a pilot screening protocol designed for cancer-prone populations will also be assessed.
Effectiveness And Cost-Effectiveness Of HPV Vaccination And HPV-Based Cervical Cancer Screening Strategies In China
Funder
National Health and Medical Research Council
Funding Amount
$420,692.00
Summary
In the absence of preventative initiatives, up to 187,000 women will develop cervical cancer in China every year. However, the disease is preventable using human papillomavirus (HPV) vaccination and primary HPV screening. Building on previous work, we will evaluate the most effective and cost-effective options for cervical cancer prevention, in order to provide an comprehensive evidence base for China’s health decision-makers.
About 14,000 cases of bowel cancer occur annually in Australia despite the availability of life-saving screening. Most people do not receive recommended screening colonoscopy. We will look at why people at high-risk avoid screening and why people at average risk seek unnecessary screening. We will analyse family history and contacts with the healthcare system that impact screening decisions. We will determine the impact of screening on reducing the number of new cases and deaths.